Good company for companies

Home
Capital Risque
Life Sciences
Communiqués de presse

Communiqués de presse Life Sciences

Gimv nouvelles

Nouvelles du portefeuille

Année:

Go

1 2

20-8-2009 ActoGeniX receives IWT grant for treatment of oral mucositis and starts clinical trial with AG013

27-2-2009 Prosensa strengthens management team

27-2-2009 Innate Pharma reports 2008 financial results

12-2-2009 Innate Pharma announces the achievement of a milestone payment in a new monoclonal antibody project developed in collaboration with Novo Nordisk A/S

10-2-2009 ActoGeniX complète son financement par capitaux propres par 13.5 millions d'euros

6-2-2009 Innate Pharma reports operating revenue of 12.9 million euros for 2008

5-2-2009 Ablynx announces second extension of its Nanobody® drug discovery and development alliance

3-2-2009 Ablynx receives €3 million in milestone payments as part of its strategic alliance with Boehringer Ingelheim

20-1-2009 Ablynx expands its musculoskeletal portfolio by taking P&G Pharmaceuticals’ programme in-house

15-1-2009 7TM Pharma closes a financing round and sells certain early stage discovery assets and technology to OSI Pharmaceuticals

1 2

Envoyez cette page Imprimez cette page